Srinivas Reddy Paladugu - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Journal of Medicinal Chemistry|May 23, 2025

Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase InhibitorsCorinne N Foley, Shiwei Qu, Srinivas Reddy Paladugu, et al.

Journal of Medicinal Chemistry|May 23, 2025

Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer TherapyDillon H Miles, Manjunath Lamani, Srinivas Reddy Paladugu, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Journal of Medicinal Chemistry|May 23, 2025

Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase InhibitorsCorinne N Foley, Shiwei Qu, Srinivas Reddy Paladugu, et al.

Journal of Medicinal Chemistry|May 23, 2025

Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer TherapyDillon H Miles, Manjunath Lamani, Srinivas Reddy Paladugu, et al.

Pageof 1